Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction
Enregistré dans:
Auteurs principaux: | Piotr Desperak, Michał Hawranek, Piotr Chodór, Andrzej Świątkowski, Jacek Kowalczyk, Andrzej Lekston, Mariusz Gąsior |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Termedia Publishing House
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/6798ebd2060341b4b64f71cc0c8167ed |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Long-term comparison of everolimus- vs.
novolimus-eluting bioresorbable vascular scaffolds
in real world patients
par: Beytullah Cakal, et autres
Publié: (2020) -
Stent Selection for Primary Angioplasty and Outcomes in the Era of Potent Antiplatelets. Data from the Multicenter Randomized Prague-18 Trial
par: Ota Hlinomaz, et autres
Publié: (2021) -
Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
par: Josep Gomez‐Lara, et autres
Publié: (2021) -
Prognostic Analysis of Patients with Acute Myocardial Infarction Undergoing Implantation of Different Stents for the First Time
par: Cheng-Chung Cheng, et autres
Publié: (2021) -
Antiplatelets in acute coronary syndrome in Poland – from guidelines to clinical practice
par: Stanisław Tubek, et autres
Publié: (2021)